General Information of Drug (ID: DMQ4L1I)

Drug Name
Dansylamide Drug Info
Synonyms
Dansylamide; 1431-39-6; 5-(dimethylamino)naphthalene-1-sulfonamide; 5-DIMETHYLAMINO-1-NAPHTHALENESULFONAMIDE; Dansyl amide; 5-Dimethylaminonaphthalene-1-sulfonamide; 5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONAMIDE; TYNBFJJKZPTRKS-UHFFFAOYSA-N; 5-[Dimethylamino]-1-naphthalenesulfonamide; 1-Naphthalenesulfonamide, 5-(dimethylamino)-; 1okl; EINECS 215-854-1; AC1Q3WHH; 5-(Dimethylamino)naphthalene-1-sulphonamide; AC1L22JG; Oprea1_628153; SCHEMBL108421; CHEMBL119489; ZINC56543; BDBM11402; TYNBFJJKZPTRKS-UHFFFAOYSA-; DTXSID70162306
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
65077
CAS Number
CAS 1431-39-6
TTD Drug ID
DMQ4L1I

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Carbonic anhydrase II (CA-II) TTANPDJ CAH2_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Carbonic anhydrase II (CA-II) DTT CA2 8.796 10.933 9.395 9.819
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Carbonic anhydrase II (CA-II) DTT CA2 7.95E-08 0.52 0.33
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.